Article PDF
References
Cherubin CE. The medical sequelae of narcotic addiction. Ann Intern Med. 1967;67:23–33.
White AG. Medical disorders in drug addicts. JAMA. 1973;223:1469–71.
Kerr P. Concerns about AIDS and crime spurring push to expand drug treatment programs. New York Times. Sept 7, 1988.
Des Jarlais DC, Friedman SR. HIV infection among persons who inject illicit drugs: problems and prospects. J AIDS. 1988;1:267–73.
Hahn RA, Onorato IM, Jones S, Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 1989;261:2677–84.
Curtis JL, Crummey FC, Baker SN, Foster RE, Khanyile CS, Wilkins R. HIV screening and counseling for intravenous drug abuse patients. JAMA. 1989;261:258–62.
Brickner PW, Torres RA, Barnes M, et al. Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users. Ann Intern Med. 1989;110:833–7.
Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study. Rev Infect Dis. 1986;8:374–96.
Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967;67:1–22.
Levine LH, Hirsch CS, White LW. Quinine cardiotoxicity: a mechanism for sudden death in narcotic addicts. J Forensic Sci. 1973;18:167–72.
Pastan RS, Silverman SL, Goldenberg DL. A musculoskeletal syndrome in intravenous heroin users—association with brown heroin. Ann Intern Med. 1977;87:22–9.
Von Glahn WC, Hall JW. The reaction produced in the pulmonary arteries by emboli of cotton fibers. Am J Pathol. 1949;25:573–9.
Lindell TD, Porter JM, Langston C. Intra-arterial injections of oral medications—a complication of drug addiction. N Engl J Med. 1972;287:1132–3.
Wright CB, Lamoy RE, Hobson RW. Hemodynamic effects of intra-arterial injection of drugs of abuse. Surgery. 1976;79:425–31.
Yeager RA, Hobson RW, Padberg FT, Lynch TG, Chakravarty M. Vascular complications related to drug abuse. J Trauma. 1987;27:305–8.
Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med. 1986;315:1495–500.
Isner JM, Estes NAM, Thompson PD, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med. 1986;315:1438–43.
Galdun JP, Paris PM, Weiss LD, Heller MB. Central embolization of needle fragments: a complication of intravenous drug abuse. Am J Emerg Med. 1987;5:379–82.
Angelos MG, Sheets CA, Zych PR. Needle emboli to lung following intravenous drug abuse. J Emerg Med. 1986;4:391–6.
Douglass RE, Levison MA. Pneumothorax in drug abusers: an urban epidemic? Am Surg. 1986;52:377–80.
Lewis JW, Groux N, Elliott JP, Jara FM, Obeid FN, Magilligan DJ. Complications of attempted central venous injections performed by drug abusers. Chest. 1980;78:613–7.
Geelhoed GW. The addict’s angioaccess. Complications of exotic vascular injection sites. N Y State J Med. 1984;84:585–6.
Pace BW, Doscher W, Margolis IB. The femoral triangle: a potential death trap for the drug abuser. N Y State J Med. 1974;84:596–8.
Garriott JC, Sturner WQ. Morphine concentrations and survival periods in acute heroin fatalities. N Engl J Med. 1973;289:1276–8.
Paranthaman SK, Khan F. Acute cardiomyopathy with recurrent pulmonary edema and hypotension following heroin overdose. Chest. 1976;69:117–9.
Labi M. Paroxysmal atrial fibrillation in heroin intoxication. Ann Intern Med. 1969;71:951–9.
Lipski J, Stimmel B, Donoso E. The effect of heroin and multiple drug abuse on the electrocardiogram. Am Heart J. 1974;86:663–8.
Huber DH. Heroin deaths—mystery or overdose? JAMA. 1974;229:689–90.
Kaufman RE, Levy SB. Overdose treatment: addict folklore and medical reality. JAMA. 1974;227:411–3.
Layon J, Idris A, Warzynski M, et al. Altered T-lymphocyte subsets in hospitalized intravenous drug abusers. Arch Intern Med. 1984;144:1376–80.
Hewlett D, Maayan S, Miller SN, et al. Reversal of T cell helper/suppressor ratios in intravenous drug abusers with nonopportunistic infections. J Infect Dis. 1985;151:748–9.
Husby G, Pierce PE, Williams RC. Smooth muscle antibody in heroin addicts. Ann Intern Med. 1975;83:801–5.
McDonough RJ, Madden JJ, Flaek A, et al. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol. 1980;125:2539–43.
Brown SM, Stimmel B, Taub RN, Kochwa S, Rosenfield RE. Immunologic dysfunction in heroin addicts. Arch Intern Med. 1974;134:1001–6.
Savona S, Nardi MA, Lennette ET, Karpatkin S. Thrombocytopenic purpura in narcotics addicts. Ann Intern Med. 1985;102:737–41.
Ryan DH. heroin and thrombocytopenia. Ann Intern Med. 1979;90:852–3.
Geller SA, Stimmel B. Diagnostic confusion from lymphatic lesions in heroin addicts. Ann Intern Med. 1973;78:703–5.
Des Jarlais DC, Friedman SR, Stoneburner RL. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis. 1988;10:151–8.
Tuazon CV, Hill R, Sheayren JN. Microbiologic study of street heroin and injection paraphernalia. J Infect Dis. 1974;129:327–9.
Tuazon CU, Elin RJ. Endotoxin content of street heroin. Arch Intern Med. 1981;141:1385–6.
Spiro TE, Jaffe R, Holland PV, et al. A study of street heroin lots for the presence of the hepatitis B surface antigen. Drug Alcohol Dep. 1978;3:393–7.
Orangio GR, Della Latta P, Marino C, et al. Infections in parenteral drug abusers, further immunologic studies. Am J Surg. 1983;146:738–41.
Orangio GR, Pitlick SD, Della Latta P, et al. Soft tissue infections in parenteral drug abusers. Ann Surg. 1984;199:97–100.
Saravolatz LD, Markowitz N, Arking LM, Pohlod D, Fisher E. Methicillin-resistantStaphylococcus aureus: epidemiologic observations during a community-acquired outbreak. Ann Intern Med. 1982;96:11–6.
Marantz PR, Linzer M, Feiner CJ, Feinstein SA, Kozin AM, Friedland GH. Inability to predict diagnosis in febrile intravenous drug abusers. Ann Intern Med. 1987;106:823–8.
Crane LR, Levine DP, Zervos MJ, Cummings G. Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis. 1986;8:364–73.
Borow KM, Alpert JS, Pennington J. Transient Pseudomonas bacteremia in a heroin addict—resemblance to right-sided endocarditis. JAMA. 1978;240:560–1.
Dunne JH, Johnson WC. Necrotizing skin lesions in heroin addicts. Arch Dermatol. 1975;105:544–7.
Webb D, Thadepolli. Skin and soft tissue polymicrobial infections from intravenous abuse of drugs. West J Med. 1979;130:200–4.
Cherubin CE. Clinical severity of tetanus in narcotic addicts in New York City. Arch Intern Med. 1968;121:156–8.
Macdonald KL, Rutherford GW, Friedman SM, et al. Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med. 1985;102:616–8.
Jacobson JM, Hirschman SZ. Necrotizing fasciitis complicating intravenous drug abuse. Arch Intern Med. 1982;142:634–5.
Firooznia H, Golimbu C, Rafii M, Lichtman EA. Radiology of musculoskeletal complications of drug addiction. Sem Roentgen. 1983;18:198–206.
Roca RP, Yoshikawa TT. Primary skeletal infections in heroin users: a clinical characterization, diagnosis and therapy. Clin Orthop. 1979;144:238–48.
Chandrasekar PH, Narula AP. Bone and joint infections in intravenous drug abusers. Rev Infect Dis. 1986;8:904–11.
Firooznia H, Seligel G, Abrams RM, Valensi V, Shamoun J. Disseminated extrapulmonary tuberculosis in association with heroin addiction. Radiology. 1973;109:291–6.
Jaffe RB. Cardiac and vascular involvement in drug abuse. Sem Roentgen. 1983;8:207–12.
Nallathambi MN, Ivatury RR, Lankin DH, Wapnir IL, Stahl WM. Pyogenic splenic abscess in intravenous drug addiction. Am Surg. 1987;53:342–6.
Fry DE, Richardson JD, Flint LM. Occult splenic abscess: an unrecognized complication of heroin abuse. Surgey. 1978;84:650–4.
Dupont B, Drouhet E. Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients. J Infect Dis. 1985;152:577–91.
Collignon PJ, Sorrell TC. Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. B Med J. 1983;287:861–2.
Collignon PJ, Sorrell T. Candidiasis in heroin addicts. J Infect Dis. 1987;155:595.
Podzamczer D, Gudiol F. Systemic candidiasis in heroin addicts. J Infect Dis. 1986;153:1182–3.
Durack DT, Beeson PB. Experimental bacterial endocarditis: I. Colonization of a sterile vegetation. Br J Exp Pathol. 1972;53:44–9.
Martin RP, Meltzer RS, Chia BL, Stinson EB, Rakowski H, Popp RL. Clinical utility of two-dimensional echocardiography in infective endocarditis. Am J Cardiol. 1980;46:379–85.
Davis RS, Strom JA, Frishman W, et al. The demonstration of vegetations by echocardiography in the evaluation of patients with infective endocarditis. Am J Cardiol. 1979;43:738–44.
Dubois RW, Ginzton LE. Role of echocardiography in suspected infective endocarditis in intravenous drug abusers. Am J Cardiol. 1986;58:649–50.
Come PC, Isaacs RE, Riley MF. Diagnostic accuracy of M-mode echocardiography in active infective endocarditis and prognostic implications of ultrasound-detectable vegetations. Am Heart J. 1982;103:839–47.
Chambers HF, Morris L, Tauber MG. Cocaine use and the risk for endocarditis in intravenous drug abusers. Ann Intern Med. 1987;106:833–6.
Scheld WM, Zak O, Vosbeck K, Sande MA. Bacterial adhesion in the pathogenesis of infective endocarditis. Effect of subinhibitory antibiotic concentrations on streptococcal adhesion in vitro and the development of endocarditis in rabbits. J Clin Invest. 1981;68:1381–4.
Ramirez-Ronda CH. Adherence of glucan-positive and glucannegative streptococcal strains to normal and damaged heart valves. J Clin Invest. 1978;62:805–14.
Neu HC, Srinivasan S. Infective endocarditis increases among narcotic addicts. J Card Med. 1981;675–87.
Bayer AS, Blomquist IK, Bello E, Chiu CY, Ward JI, Ginzton LE. Tricuspid valve endocarditis due toStaphylococcus aureus: correlation of two-dimensional echocardiography with clinical outcome. Chest. 1988;2:247–53.
Reiner NE, Gopalakrishna KV, Lerner PI. Enterococcal endocarditis in heroin addicts. JAMA. 1976;235:1861–3.
Barg NL, Kish MA, Kauffman CA, Supena RB. Group A streptococcal bacteremia in intravenous drug abusers. Am J Med. 1985;78:569–74.
Gerac JE, Wilson WR. Symposium in infective endocarditis. III. Endocarditis due to gram-negative bacteria: report to 56 cases. Mayo Clin Proc. 1982;57:145–8.
Wong D, Chandraratna PAN, Wishnow RM, Dusitnanond V, Nimalasuriya A. Clinical implications of large vegetations in infectious endocarditis. Arch Intern Med. 1983;143:1874–7.
Saravolatz LD, Burch KH, Quinn EL, Cox F, Madhavan T, Fisher E. Polymicrobial infective endocarditis: an increasing clinical entity. Am Heart J. 1978;95:163–8.
Korzeniowski O., Sande MA, and the National Collaborative Endocarditis Study Group. Combination antimicrobial therapy forStaphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med. 1982;97:496–503.
Chambers HF, Miller RT, Newman MD. Right-sidedStaphylococcus aureus endocarditis in intravenous drug abusers: two week combination therapy. Ann Intern Med. 1988;109:619–24.
Denbile M. Surgery for addiction related tricuspid valve endocarditis: caveat emptor. Am J Med. 1987;82:811–3.
Denubile MJ. Surgery in active endocarditis. Ann Intern Med. 1982;96:650–9.
Frand UI, Shim CS, Williams MH. Heroin-induced pulmonary edema. Sequential studies of pulmonary function. Ann Intern Med. 1972;77:29–35.
Saba GP, James AE, Johnson BA, et al. Pulmonary complications of narcotic abuse. AJR. 1974;122:733–9.
Stern WZ, Subbarao K. Pulmonary complications of drug addiction. Semin Roentgenol. 1983;18:183–97.
Louria DB. Lung disease in heroin addicts. JAMA. 1982;248:2536.
Helpern M. Fatalities from narcotic addiction in New York City. Incidence, circumstances, and pathologic findings. Hum Pathol. 1972;3:13–21.
Katz S, Aberman A, Frand UI, et al. Heroin pulmonary edema. Evidence for increased pulmonary capillary permeadility. Am Rev Respir Dis. 1972;106:472–4.
Felman AH. Neurogenic pulmonary edema. AJR. 1971;112:393–6.
Phillips JF, Neiman HL, Reeder MM. Noncardiac causes of pulmonary edema. JAMA. 1975;234:531–2.
Warnock ML, Ghahremani GG, Rattenborg C, Ginsberg M, Valanyuela J. Pulmonary complications of heroin intoxication: aspiration pneumonia and diffuse bronchiectasis. JAMA. 1972;219:1051–3.
Anderson K. Bronchospasm and intravenous street heroin. Lancet. 1986;1:1208.
Jaffe RB, Koschmann EB. Septic pulmonary emboli. Radiology. 1970;96:527–32.
Danner PK, McFarland DR, Felson B. Massive pulmonary gangrene. AJR. 1968;103:548–54.
Lamb D, Roberts G. Starch and talc emboli in drug addicts’ lungs. J Clin Pathol. 1972;25:876–81.
Pare PJA, Fraser RG, Hogg JC, Howlett SG, Murphy JB. Pulmonary “mainline” granulomatosis: talcosis of intravenous methadone abuse. Medicine. 1979;58:229–39.
Robertson CH, Reynolds RC, Wilson JE. Pulmonary hypertension and foreign body granulomas in intravenous drug abusers. Documentation by cardiac catheterization and lung biopsy. Am J Med. 1976;61:657–64.
Farber HW, Fairman RP, Glauser FL. Talc granulomatosis: laboratory findings similar to sarcoidosis. Am Rev Respir Dis. 1982;125:259–61.
Overland ES, Nolan AJ, Hopewell PC. Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities. Am J Med. 1980;68:231–7.
Camargo G, Cold C. Pulmonary function studies in ex-heroin users. Chest. 1975;67:331–4.
Soin JS, Wagner HN, Thomashow D, Brown TC. Increased sensitivity of regional measurements in early detection of narcotic lung disease. Chest. 1975;325–30.
Goldstein DS, Karpel JP, Appel D, Williams MH. Bullous pulmonary damage in users of intravenous drugs. Chest. 1986;89:266–9.
Sieniewicz DJ, Nidecker AC. Conglomerate pulmonary disease: a form of talcosis in intravenous methadone abusers. AJR. 1980;135:697–702.
Richter RW, Challenor YB, Pearson J, Kagen LJ, Hamilton LL, Ramsey WH. Acute myoglobinuria associated with heroin addiction. JAMA. 1971;216:1172–6.
Schreiber SN, Liebowitz MR, Bernstein LH, et al. Limb compression and renal impairment (crush syndrome) complicating narcotic overdose. N Engl J Med. 1971;284:368–9.
Tu WH, Shearn MA, Lee JC. Acute diffuse glomerulonephritis in acute staphylococcal endocarditis. Ann Intern Med. 1969;71:335–41.
Melchior J, Mebust WK, Valk WL. Ureteral colic from a fungus ball: unusual presentations of systemic aspergillosis. J Urol. 1972;108:698–9.
Levy M, Kleinknecht C. Membranous glomerulonephritis and hepatitis B virus infection. Nephron. 1980;26:259–65.
Kohler PF, Cronin RE, Hammond WS, Olin D, Carr RI. Chronic membranous glomerulonephritis caused by hepatitis B antigen-antibody immune complexes. Ann Intern Med. 1974;81:448–51.
Eknoyan G, Gyorkey F, Dischoso C, et al. Renal involvement in drug abuse. Arch Intern Med. 1973;132:801–6.
Citron BP, Halpern M, McCarron M, et al. Necrotizing angiitis associated with drug abuse. N Engl J Med. 1970;283:1003–11.
Salomon MI, Pui Poon T, Goldblatt M, et al. Renal lesions in heroin addicts—a study based on kidney biopsies. Nephron. 1972;9:356–63.
Cunningham EE, Brentjens JR, Zielezny MA, Andres GA, Venuto RC. Heroin nephropathy: a clinicopathologic and epidemiologic study. Am J Med. 1980;68:47–53.
Treser G, Cherubin C, Lonergan ET, et al. Renal lesions in narcotic addicts. Am J Med. 1974;57:687–94.
Rao TKS, Nicastri AD, Friedman EA. Natural history of heroinassociated nephropathy. N Engl J Med. 1974;290:19–23.
McGinn JT, McGinn TG, Hoffman RS. Nephrotic syndrome in heroin and cocaine addicts. Clin Res. 1970;18:699.
Kilcoyne MM, Daly JJ, Gocke DJ, et al. Nephrotic syndrome in heroin addicts. Lancet. 1972;1:17–20.
Friedman EA, Rao TKS. Why does uremia in heroin abusers occur predominantly among blacks? JAMA. 1983;250:2965–6.
Marchand G, Cantin M, Cote M. Evidence for the nephrotoxicity of morphine sulfate in rats. Can J Physiol Pharmacol. 1969;47:649–55.
Cunningham EE, Zielezny MA, Venuto RC. Heroin-associated nephropathy: a nationwide problem. JAMA. 1983;250:2935–6.
Ross G, Weinstein S, Dutton S, Whittier FC. Renal transplantation in the end stage renal disease of drug abuse. J Urol. 1983;129:14–5.
Neugarten J, Gallo GR, Buxbaum J, Katz LA, Rubenstein J, Baldwin DS. Amyloidosis in subcutaneous heroin abusers (“skin poppers’ amyloidosis”) Am J Med. 1986;81:635–40.
Menchel S, Cohen D, Gross E, Frangione B, Gallo G. AA proteinrelated renal amyloidosis in drug addicts. Am J Pathol. 1983;112:195–9.
Meador KH, Sharon Z, Lewis EJ. Renal amyloidosis and subcutaneous drug abuse. Ann Intern Med. 1979;91:565–7.
Jacob H, Charytan C, Rascoff JH, Golden R, Janis R. Amyloidosis secondary to drug abuse and chronic skin suppuration. Arch Intern Med. 1978;138:1150–1.
Ferraro EM, Alfelor FR, Lee M, Poon TT. Hepatic amyloidosis in an IV drug abuser detected by bone scintigraphy. Clin Nuc Med. 1987;12:274–6.
Derosena R, Koss MN, Pirani CL. Demonstration of amyloid fibrils in urinary sediment. N Engl J Med. 1975;293:1131–3.
Dikman SH, Kahn T, Gribetz D, Churg J. Resolution of renal amyloidosis. Am J Med. 1977;63:430–3.
Francis DP, Hadler SC, Prendergast TJ, et al. Occurrence of hepatitis A, B, and non-A/non-B in the United States—CDC Sentinel County Hepatitis Study 1. Am J Med. 1984;76:69–74.
Kreek MJ, Dodes L, Kanes S, Knobler J, Martin R. Long-term methadone maintenance therapy: effects on liver function. Ann Intern Med. 1972;77:598–602.
Novick DM, Gelb AM, Stenger RJ, et al. Hepatitis B serologic studies in narcotic users with chronic liver disease. Am J Gastroenterol. 1981;75:111–5.
Center for Disease Control. Hepatitis B—New Bern, North Carolina. MMWR. 1979;28:373–4.
Min K, Gyorkey F, Cain GD. Talc granulomata in liver disease in narcotic addicts. Arch Pathol. 1974;98:331–5.
Cherubin CE, Rosenthal WS, Stenger RE, et al. Chronic liver disease in asymptomatic narcotic addicts. Ann Intern Med. 1972;76:391–5.
Kunches LM, Craven DE, Werner BG. Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers—immunogenicity of hepatitis B vaccine. Am J Med. 1986;81:591–5.
Seeff LB. Hepatitis in the drug abuser. Med Clin North Am. 1975;59:843–8.
Mosley JW, Redeker AG, Feinstone SM, Purcell RH, Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med. 1977;296:75–80.
Lettau LA, McCarthy JG, Smith MH, et al. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med. 1987;317:1256–61.
Shattock AG, Irwin FM, Morgan BM, et al. Increased severity and morbidity of acute hepatitis in drug abusers with simultaneously acquired hepatitis B and hepatitis D virus infections. Br Med J. 1985;290:1377–80.
Hansson BG, Moestrup T, Widell A, Nordenfelt E. Infection with delta agent in Sweden: introduction of a new hepatitis agent. J Infect Dis. 1982;146:472–8.
Nishioka NS, Dienstag JL. Delta hepatitis—a new scourge? N Engl J Med. 1985;312:1515–6.
De Cock KM, Govindarajan S, Chin KP, Redeker AG. Delta hepatitis in the Los Angeles area: a report of 126 cases. Ann Intern Med. 1986;105:108–14.
Govindarajan S, Valinluck B, Peters RL. Relapse of acute B viral hepatitis: the role of delta agent. Gut. 1986;27:19–22.
Shih JWK, Esteban JI, Alter HJ. Non-A, non-B hepatitis: advances and unfulfilled expectations of the first decade. Progr Liver Dis. 1986;8:433–52.
Hoofnagle KH, Gerety RJ, Tabor E, Feinstone SH, Barker LF, Purcell RH. Transmission of non-A, non-B hepatitis. Ann Intern Med. 1977;87:14–20.
Hollinger FB, Khan NC, Oefinger PE, et al. Posttransfusion hepatitis type A. JAMA. 1983;250:2313–7.
Moestrup T, Hansson BG, Widell A, Nordenfelt E, Hagerstrand I. Long term follow up of chronic hepatitis B virus infection in intravenous drug abusers and homosexual men. Br Med J. 1986;292:854–7.
Kanel GC, Govindarajan S, Peters RL. Chronic delta infection and liver biopsy changes in chronic active hepatitis B. Ann Intern Med. 1984;101:51–4.
Richter RW, Pearson J, Bruun B, Challenor YB, Brust JCM, Baden MM. Neurological complications of addiction to heroin. Bull NY Acad Med. 1973;49:3–21.
Rubin AM. Neurologic complications of intravenous drug abuse. Hosp Pract. 1987;(15 April)279–88.
Mittelman RE, Wetli CV. Death caused by recreational cocaine use—an update. JAMA. 1984;252:1889–93.
Smith WR, Wilson AF. Guillain-Barré syndrome in heroin addiction. JAMA. 1975;231:1367–8.
Additional information
Received from the Division of General Internal Medicine, Brown University, Rhode Island Hospital, 593 Eddy Street, Providence, Rhode Island 02903.
Rights and permissions
About this article
Cite this article
Stein, M.D. Medical complications of intravenous drug use. J Gen Intern Med 5, 249–257 (1990). https://doi.org/10.1007/BF02600544
Issue Date:
DOI: https://doi.org/10.1007/BF02600544